Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Keng

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Cancer Science|March 25, 2016
Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancerFuquan Zhang, Shanzhou Duan, Ying Tsai, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 13, 2019
Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signalingFeng Chen, Xiaodong Chen, Yu Ren, et al.
The Prostate|July 24, 2019
Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancerXiaodong Chen, Feng Chen, Yu Ren, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|January 7, 2018
FASN-TGF-β1-PD-L1 axis contributes to the development of resistance to NK cell cytotoxicity of cisplatin-resistant lung cancer cellsMingjing Shen, Ying Tsai, Rongying Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancerYuhchyau Chen, Kishan J Pandya, Richard Feins, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 26, 2003
The Cdk and PCNA domains on p21Cip1 both function to inhibit G1/S progression during hyperoxiaChristopher E Helt, Rhonda J Staversky, Yi-Jang Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy: a therapeutic approach on the basis of preclinical research of human cancer cell linesYuhchyau Chen, Kishan Pandya, Peter C Keng, et al.
BMC Cancer|December 13, 2005
Caffeic acid phenethyl ester decreases acute pneumonitis after irradiation in vitro and in vivoMiao-Fen Chen, Peter C Keng, Paul-Yang Lin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 20, 2004
In vivo exposure to hyperoxia induces DNA damage in a population of alveolar type II epithelial cellsJason M Roper, Dawn J Mazzatti, Richard H Watkins, et al.
Experimental Cell Research|December 4, 2018
NFκB and TNFα as individual key molecules associated with the cisplatin-resistance and radioresistance of lung cancerRongying Zhu, Xiang Xue, Mingjing Shen, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Cancer Science|March 25, 2016
Cisplatin treatment increases stemness through upregulation of hypoxia-inducible factors by interleukin-6 in non-small cell lung cancerFuquan Zhang, Shanzhou Duan, Ying Tsai, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 13, 2019
Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signalingFeng Chen, Xiaodong Chen, Yu Ren, et al.
The Prostate|July 24, 2019
Glucocorticoid receptor upregulation increases radioresistance and triggers androgen independence of prostate cancerXiaodong Chen, Feng Chen, Yu Ren, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|January 7, 2018
FASN-TGF-β1-PD-L1 axis contributes to the development of resistance to NK cell cytotoxicity of cisplatin-resistant lung cancer cellsMingjing Shen, Ying Tsai, Rongying Zhu, et al.
International Journal of Radiation Oncology, Biology, Physics|January 1, 2008
Toxicity profile and pharmacokinetic study of a phase I low-dose schedule-dependent radiosensitizing paclitaxel chemoradiation regimen for inoperable non-small-cell lung cancerYuhchyau Chen, Kishan J Pandya, Richard Feins, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|August 26, 2003
The Cdk and PCNA domains on p21Cip1 both function to inhibit G1/S progression during hyperoxiaChristopher E Helt, Rhonda J Staversky, Yi-Jang Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy: a therapeutic approach on the basis of preclinical research of human cancer cell linesYuhchyau Chen, Kishan Pandya, Peter C Keng, et al.
BMC Cancer|December 13, 2005
Caffeic acid phenethyl ester decreases acute pneumonitis after irradiation in vitro and in vivoMiao-Fen Chen, Peter C Keng, Paul-Yang Lin, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|January 20, 2004
In vivo exposure to hyperoxia induces DNA damage in a population of alveolar type II epithelial cellsJason M Roper, Dawn J Mazzatti, Richard H Watkins, et al.
Experimental Cell Research|December 4, 2018
NFκB and TNFα as individual key molecules associated with the cisplatin-resistance and radioresistance of lung cancerRongying Zhu, Xiang Xue, Mingjing Shen, et al.
Pageof 6